Recognizing warning signs ensures timely intervention and prevents serious complications
As in the previously mentioned study there was no difference between GLP-1 receptor agonists and SGLT2 inhibitors in reducing the risk of MACE, but when compared to DPP-4 inhibitors SGLT2 inhibitors significantly reduced cardiovascular and total death
The receptor overlap creates compounding effects that dramatically increase side effect risk without proportional benefit
Convenient, discreet use at home when prescribed through telehealth programs
Cutting-Edge Treatments: As part of our commitment to offering the most effective, evidence-based care, we provide the latest weight loss treatments and technologies, including GLP-1 inhibitors like Ozempic and Wegovy, that are proven to help people lose weight and improve their health
New compounds typically launch at a premium